您的位置: 首页 > 农业专利 > 详情页

Anti-prokineticin receptor (PROKR) antibodies and uses thereof
专利权人:
Regeneron Pharmaceuticals; Inc.
发明人:
Lynn Macdonald,Michael L. LaCroix-Fralish
申请号:
US14678347
公开号:
US09951132B2
申请日:
2015.04.03
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides antibodies that bind to prokineticin receptors (PROKRs) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human PROKR1 and/or PROKR2. The present invention includes antibodies that bind cell surface-expressed PROKR1 and/or PROKR2. In certain embodiments, the antibodies of the present invention are capable of blocking prokineticin (PK)-mediated activation of one or more PROKR. The antibodies of the invention are useful for the treatment of various diseases and disorders mediated by prokineticin signaling.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充